Users Coming Off Anti-Obesity Injections Gain Back Weight Four Times Faster Than Those on Conventional Diets

Fresh analysis indicates that people who discontinue new GLP-1 drugs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who end conventional diet and exercise programs.

Published data in a major health publication demonstrates that while obese individuals often shed about a fifth of their total mass while on the medication, the mass comes back at an average rate of 0.8 kg per month after stopping.

"People purchasing these treatments must be cognizant of the risk of quick weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

That rate of recovery implies a reversion to starting mass within about a year and a half.

Analyzing Approaches

The research, which examined dozens of studies involving over 9,000 of patients, compared the results of these new drugs with conventional dieting.

Researchers point out that individuals who lose weight through diet and exercise generally have a less rapid weight regain—around 100 grams monthly—post-intervention.

Understanding the Fast Regain

Experts propose the mechanism of the drugs is key to understanding the accelerated regain.

GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which controls hunger.

"Sustained high doses of GLP-1 concentrations several times higher than normal could lead to the system to produce less of its own natural GLP-1, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this medication means appetite is no longer kept in check, making binge eating a significant risk."

A Lifelong Disease?

The NHS suggest the jabs for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.

A number of clinicians say that, due to the significant potential of relapse, the treatment might need to be long-term.

This opinion is supported by drug manufacturers, who say that the findings "highlight the long-term character of excess weight," comparing it to managing diseases like hypertension.

Patient Testimonies

People who have discontinued the medication describe a sudden resurgence of hunger.

"It was like a switch activating and you're instantly extremely hungry," said one woman.

The struggle is compounded if patients have not established sustainable lifestyle or habit changes during therapy.

Widespread Adoption

Figures indicate that millions of people in the UK have tried weight-loss jabs in the past year, with desire being substantial.

• Adoption is greater among women compared to males.
• The middle-aged age group shows the greatest usage rates.
• Many access the medications through private healthcare rather than the NHS.

Ultimately, clinicians stress that while these medications are powerful tools for shedding pounds, they are not a magic solution and maintained weight loss hinges on ongoing behavioural support.